NewGen Surgical, Inc.
USPTO PatentsView assignee record - 12 granted patents across 1 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Newgen ranks #23,074 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 1 technology areas.
- #23,074
- of 49,997 US assignees by volume
- 7th percentile
- by Innovation Score (20.4/100)
- 4.9
- avg claims per patent
- +0%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R23074 · US Corporation #23,074 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL
- GRANTS-MICRO 12 grants
- MID-PACK #23,074/49,997
- PHOTO-FINISH Neuropore Therapies
- CPC-NARROW A61B · 1 areas
- INNOV-THIN 20.4/100
- CLAIMS-SPARSE 4.9 claims/avg
- TYPE-USCORP US Corporation
- VEL-FLAT +0% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Neuropore Therapies, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Newgen’s 20.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Newgen
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- NewGen Surgical · this assignee 20
NewGen Surgical · this assignee
20 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Newgen's Innovation Score is 20.4/100 (7th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Newgen?
Each dot is one of Newgen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Newgen’s own 4.9 claims/patent is at or below the 12.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Newgen's grants concentrate
NewGen Surgical, Inc. is a focused PatentsView assignee: 1 CPC subclasses with 25% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2019. By volume, Newgen sits between Neuropore Therapies, Inc. and Ningbo Yousun Imp. and Exp. Co., Ltd.
Newgen's three-year grant acceleration
NewGen Surgical, Inc. shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at NewGen's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Neuropore Therapi…
Neuropore Therapies, Inc.
12 patents
- Neurostructures
Neurostructures, Inc.
12 patents
- Nevada Nanotech S…
Nevada Nanotech Systems Inc.
12 patents
- New Wave Endo-sur…
New Wave Endo-Surgical Corp.
12 patents
- Newpace
NewPace Ltd.
12 patents
- Nextek Power Syst…
Nextek Power Systems, Inc.
12 patents
- Ningbo Forward Pl…
Ningbo Forward Plastic Co., Ltd.
12 patents
- Ningbo Yousun Imp…
Ningbo Yousun Imp. and Exp. Co., Ltd
12 patents
- Newgen Surgical ◀
NewGen Surgical, Inc.
12 patents
What this shows NewGen holds 12 patents at rank #23,092, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near NewGen
By rank, the assignees closest to #23,092 in granted patent volume.
- Neuropore Therapies, Inc. #23,088 · 12 patents
- Neurostructures, Inc. #23,089 · 12 patents
- Nevada Nanotech Systems Inc. #23,090 · 12 patents
- New Wave Endo-Surgical Corp. #23,091 · 12 patents
- NewPace Ltd. #23,093 · 12 patents
- Nextek Power Systems, Inc. #23,094 · 12 patents
- Ningbo Forward Plastic Co., Ltd. #23,095 · 12 patents
- Ningbo Yousun Imp. and Exp. Co., Ltd #23,096 · 12 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in NewGen's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Newgen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
20 7th percentile higher than 7% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 16.7% |
| 2017 | 3 | 25.0% |
| 2019 | 1 | 8.3% |
| 2020 | 3 | 25.0% |
| 2022 | 2 | 16.7% |
| 2024 | 1 | 8.3% |
Which technologies does NewGen Surgical, Inc. patent most?
Top 1 of 1 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
NewGen Surgical, Inc.'s patent record in context - here's where to go next.
- NewGen Surgical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 25% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #23,074 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare NewGen Surgical, Inc. against Neuropore Therapies, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 20.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.